A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs

Iron is a trace but vital element in the human body and is necessary for a multitude of crucial processes in life. However, iron overload is known to induce carcinogenesis via oxidative stress. Cancer cells require large amounts of iron for their rapid division and cell growth. Iron was recently fou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta medica Okayama 2020-02, Vol.74 (1), p.1-6
Hauptverfasser: Chen, Yuehua, Ohara, Toshiaki, Xing, Boyi, Qi, Jiping, Noma, Kazuhiro, Matsukawa, Akihiro
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6
container_issue 1
container_start_page 1
container_title Acta medica Okayama
container_volume 74
creator Chen, Yuehua
Ohara, Toshiaki
Xing, Boyi
Qi, Jiping
Noma, Kazuhiro
Matsukawa, Akihiro
description Iron is a trace but vital element in the human body and is necessary for a multitude of crucial processes in life. However, iron overload is known to induce carcinogenesis via oxidative stress. Cancer cells require large amounts of iron for their rapid division and cell growth. Iron was recently found to play a role in cancer stem cells (CSCs); it maintains stemness during development. Iron also plays an important role in stemness by moderating reactive oxygen species. Thus, iron metabolism in CSCs is a promising therapeutic target. In this review, we summarize the roles of iron in cancer cells and CSCs. We also summarize anti-cancer therapeutic studies with iron chelators and describe our expectation of a new therapeutic strategy for CSCs on the basis of our findings.
doi_str_mv 10.18926/AMO/57946
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2365207298</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2365207298</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-c316487e9ae06d8b130c011cdea9742187745e3d40861d01b1e7adf69251a0733</originalsourceid><addsrcrecordid>eNo1jz1PwzAYhD2AaCks_ADkkSX0tZ34gy2y-KhUKFKLxBa5ydsSlCbFdoT67wmiLHfL3ek5Qq4Y3DJtuJzmz4tppkwqT8gYhJaJAHgfkfMQPgF4aiSckZHgYAxP-ZjYnL76bleHut3SF_ymeRvrxLq2RE-X0buI28MdnfmupfYDGxc7H-jK-S3G34pd2nBBTjeuCXh59Al5e7hf2adkvnic2XyelANHHJTJVCs0DkFWes0ElMBYWaEzKuVMK5VmKKoUtGQVsDVD5aqNNDxjDpQQE3Lzt7v33VePIRYDd4lN41rs-lBwITMOihs9RK-P0X69w6rY-3rn_KH4Py5-AJryVQM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2365207298</pqid></control><display><type>article</type><title>A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs</title><source>Freely Accessible Japanese Titles</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Chen, Yuehua ; Ohara, Toshiaki ; Xing, Boyi ; Qi, Jiping ; Noma, Kazuhiro ; Matsukawa, Akihiro</creator><creatorcontrib>Chen, Yuehua ; Ohara, Toshiaki ; Xing, Boyi ; Qi, Jiping ; Noma, Kazuhiro ; Matsukawa, Akihiro</creatorcontrib><description>Iron is a trace but vital element in the human body and is necessary for a multitude of crucial processes in life. However, iron overload is known to induce carcinogenesis via oxidative stress. Cancer cells require large amounts of iron for their rapid division and cell growth. Iron was recently found to play a role in cancer stem cells (CSCs); it maintains stemness during development. Iron also plays an important role in stemness by moderating reactive oxygen species. Thus, iron metabolism in CSCs is a promising therapeutic target. In this review, we summarize the roles of iron in cancer cells and CSCs. We also summarize anti-cancer therapeutic studies with iron chelators and describe our expectation of a new therapeutic strategy for CSCs on the basis of our findings.</description><identifier>ISSN: 0386-300X</identifier><identifier>DOI: 10.18926/AMO/57946</identifier><identifier>PMID: 32099242</identifier><language>eng</language><publisher>Japan</publisher><ispartof>Acta medica Okayama, 2020-02, Vol.74 (1), p.1-6</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-c316487e9ae06d8b130c011cdea9742187745e3d40861d01b1e7adf69251a0733</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32099242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Yuehua</creatorcontrib><creatorcontrib>Ohara, Toshiaki</creatorcontrib><creatorcontrib>Xing, Boyi</creatorcontrib><creatorcontrib>Qi, Jiping</creatorcontrib><creatorcontrib>Noma, Kazuhiro</creatorcontrib><creatorcontrib>Matsukawa, Akihiro</creatorcontrib><title>A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs</title><title>Acta medica Okayama</title><addtitle>Acta Med Okayama</addtitle><description>Iron is a trace but vital element in the human body and is necessary for a multitude of crucial processes in life. However, iron overload is known to induce carcinogenesis via oxidative stress. Cancer cells require large amounts of iron for their rapid division and cell growth. Iron was recently found to play a role in cancer stem cells (CSCs); it maintains stemness during development. Iron also plays an important role in stemness by moderating reactive oxygen species. Thus, iron metabolism in CSCs is a promising therapeutic target. In this review, we summarize the roles of iron in cancer cells and CSCs. We also summarize anti-cancer therapeutic studies with iron chelators and describe our expectation of a new therapeutic strategy for CSCs on the basis of our findings.</description><issn>0386-300X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo1jz1PwzAYhD2AaCks_ADkkSX0tZ34gy2y-KhUKFKLxBa5ydsSlCbFdoT67wmiLHfL3ek5Qq4Y3DJtuJzmz4tppkwqT8gYhJaJAHgfkfMQPgF4aiSckZHgYAxP-ZjYnL76bleHut3SF_ymeRvrxLq2RE-X0buI28MdnfmupfYDGxc7H-jK-S3G34pd2nBBTjeuCXh59Al5e7hf2adkvnic2XyelANHHJTJVCs0DkFWes0ElMBYWaEzKuVMK5VmKKoUtGQVsDVD5aqNNDxjDpQQE3Lzt7v33VePIRYDd4lN41rs-lBwITMOihs9RK-P0X69w6rY-3rn_KH4Py5-AJryVQM</recordid><startdate>202002</startdate><enddate>202002</enddate><creator>Chen, Yuehua</creator><creator>Ohara, Toshiaki</creator><creator>Xing, Boyi</creator><creator>Qi, Jiping</creator><creator>Noma, Kazuhiro</creator><creator>Matsukawa, Akihiro</creator><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202002</creationdate><title>A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs</title><author>Chen, Yuehua ; Ohara, Toshiaki ; Xing, Boyi ; Qi, Jiping ; Noma, Kazuhiro ; Matsukawa, Akihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-c316487e9ae06d8b130c011cdea9742187745e3d40861d01b1e7adf69251a0733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Yuehua</creatorcontrib><creatorcontrib>Ohara, Toshiaki</creatorcontrib><creatorcontrib>Xing, Boyi</creatorcontrib><creatorcontrib>Qi, Jiping</creatorcontrib><creatorcontrib>Noma, Kazuhiro</creatorcontrib><creatorcontrib>Matsukawa, Akihiro</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Acta medica Okayama</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Yuehua</au><au>Ohara, Toshiaki</au><au>Xing, Boyi</au><au>Qi, Jiping</au><au>Noma, Kazuhiro</au><au>Matsukawa, Akihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs</atitle><jtitle>Acta medica Okayama</jtitle><addtitle>Acta Med Okayama</addtitle><date>2020-02</date><risdate>2020</risdate><volume>74</volume><issue>1</issue><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>0386-300X</issn><abstract>Iron is a trace but vital element in the human body and is necessary for a multitude of crucial processes in life. However, iron overload is known to induce carcinogenesis via oxidative stress. Cancer cells require large amounts of iron for their rapid division and cell growth. Iron was recently found to play a role in cancer stem cells (CSCs); it maintains stemness during development. Iron also plays an important role in stemness by moderating reactive oxygen species. Thus, iron metabolism in CSCs is a promising therapeutic target. In this review, we summarize the roles of iron in cancer cells and CSCs. We also summarize anti-cancer therapeutic studies with iron chelators and describe our expectation of a new therapeutic strategy for CSCs on the basis of our findings.</abstract><cop>Japan</cop><pmid>32099242</pmid><doi>10.18926/AMO/57946</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0386-300X
ispartof Acta medica Okayama, 2020-02, Vol.74 (1), p.1-6
issn 0386-300X
language eng
recordid cdi_proquest_miscellaneous_2365207298
source Freely Accessible Japanese Titles; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T21%3A42%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Promising%20New%20Anti-Cancer%20Strategy:%20Iron%20Chelators%20Targeting%20CSCs&rft.jtitle=Acta%20medica%20Okayama&rft.au=Chen,%20Yuehua&rft.date=2020-02&rft.volume=74&rft.issue=1&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=0386-300X&rft_id=info:doi/10.18926/AMO/57946&rft_dat=%3Cproquest_pubme%3E2365207298%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2365207298&rft_id=info:pmid/32099242&rfr_iscdi=true